Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EUDA news
17. December 2025 Shedding light on drug-related hospital emergencies in Europe Every year, thousands of people across Europe require hospital treatment for drug-related poisoning and other acute harms. In...
